Age-based and sex-based disparities in screening colonoscopy use among medicare beneficiaries

Journal of Clinical Gastroenterology

Volumn 47, Issue 7, 2013, Pages 630-636

  Gancayco, John ^a   Soulos, Pamela R ^b,c   Khiani, Vijay ^d   Cramer, Laura D ^b,c   Ross, Joseph S ^b,c   Genao, Inginia ^b   Tinetti, Mary ^e   Gross, Cary P ^b,c  

^a Digestive Diseases   (United States)

^b General Internal Medicine   (United States)

^c YALE CANCER CENTER   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

age; colonoscopy; colorectal cancer; life expectancy; Medicare; screening; sex

Indexed keywords

AGED; ARTICLE; COLONOSCOPY; COLORECTAL CANCER; FEMALE; HEALTH DISPARITY; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; SCREENING;

AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HEALTHCARE DISPARITIES; HUMANS; LIFE EXPECTANCY; MALE; MASS SCREENING; MEDICARE; RETROSPECTIVE STUDIES; SEER PROGRAM; SEX FACTORS; UNITED STATES;

EID: 84880743968     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31828345c8     Document Type: Article

References (31)

1. Mandel J, Bond J, Church T. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365-1371.
2. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonscopic polypectomy. N Engl J Med. 1993;329:1977-1981.
3. Hardcastle JD, Chamberlain J, Robinson MH, et al. Randomised controlled trial of faecal-occult blood screening for colorectal cancer. Lancet. 1996;348:1472-1477.
4. Centers for Disease Control and Prevention (CDC). Vital signs: colorectal cancer screening among adults 50-75 years- United States. 2008. Morb Mortal Wkly Rep. 2010;1-5.
5. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Inter Med. 2008;149:627-637.
6. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology Guidelines for colorectal cancer screening 2008. Am J Gastroenterol. 2009;104:739-750.
7. Schenck AP, Klabunder CN, Warren JL, et al. Data sources for measuring colorectal endoscopy use among Medicare enrollees. Biomarkers Prev. 2007;16:2118-2127.
8. Klabunde CN, Lanier D, Nadal MR. Colorectal cancer screening by primary care physicians: recommendations and practices 2006-2007. Am J Prev Med. 2009;37:8-16.
9. Seeff LR, Richards TBRT, Shapiro JA, et al. How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology. 2004;127:1670-1677.
10. Cooper GS, Doug Kou T. Underuse of colorectal cancer screening in cohort of Medicare benficiaries. Cancer. 2008; 112:292-299.
11. Chen X, White MC, Peipins LA, et al. Increase in screening for colorectal cancer in older Americans. J Am Geriatrics Soc. 2008;56:1511-1516.
12. American Geriatrics Society Ethics Committee. Health screening decisions for older adults: AGS Position Paper. J Am Geriatr Soc. 2003;51:270-271.
13. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA. 2001;285:2750-2756.
14. Ko CW, Kreuter W, Baldwin LM. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement. BMC Gastroenterol. 2005; 5:5-10.
15. Ananthakrishnam AN, Schellhase K, Sparapani RA, et al. Disparities in colon cancer screening in the Medicare population. Arch Intern Med. 2007;167:258-264.
16. Ko CW, Kreuter W, Baldwin LM. Effect of Medicare coverage on use of invasive colorectal cancer screening tests. Arch Intern Med. 2002;162:2581-2586.
17. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998; 36:8-27.
18. Beck JR, Kassirer JP, Pauker SG. A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. Am J Med. 1982;73:883-888.
19. Welch HG, Albertsen PC, Nease RF, et al. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med. 1996;124:577-584.
20. Inadomi JM, Sonnenberg A. The impact of colorectal cancer screening on life expectancy. Gastrointest Endosc. 2000;51: 517-523.
21. Anderson GF. Medicare and chronic conditions. N Engl J Med. 2005;353:305-309.
22. Menotti A, Mulder I, Nissinen A, et al. Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortality: The FINE study (Finland, Italy, Netherlands, Elderly). J Clin Epidemiol. 2001;54:680-686.
23. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162:2269-2276.
24. Fenton JJ, Cai Y, Beckett LA, et al. Trends in colorectal cancer among Medicare subpopulations. Am J Prev Med. 2008;35: 194-202.
25. Menees S. Women patient's preference for women physicians is a barrier to colon cancer screening. Gastrointest Endosc. 2005;62:219-223.
26. Etzioni DA, Ponce NA, Spencer BA, et al. A population-based study of colorectal cancer test use. Cancer. 2004;101: 2523-2532.
27. Meissner HI, Breen N, Klabunde CN, et al. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15:389-394.
28. Seeff LC, Nadal MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004;100:2093-2102.
29. Gross CP, McAvay GJ, Krumholz HM, et al. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Ann Intern Med. 2006;145:646-653.
30. Alibhai SM, Horgan AM. Cancer screening in older adults: what to do when we don't know. J Geriatr Oncol. 2011;2: 149-160.
31. Vedel I, Monette M, Monette J, et al. Barriers and facilitators tp breast and colorectal cancer screening of older adults in primary care: a systemic review. J Geriatr Oncol. 2011;2:85-98.